News Center

First US Patient Dosed With Investigational Stem Cell Therapy IMS001 for MS

11/23 . 2021

The first US patient has been dosed with an investigational stem cell therapy called IMS001, for multiple sclerosis (MS), developed by ImStem Biotechnology.

< 1234 >